PHOENIX — Urticaria and/or angioedema events comprised 13% of the adverse reports from clinicians after mRNA vaccinations for COVID-19, according to a presentation at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

PHOENIX — Tezepelumab consistently reduced exacerbations in adults and adolescents with severe asthma across all seasons, according to NAVIGATOR trial results presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

PHOENIX — Allergens should not be avoided but rather introduced early and often into an infant’s diet to reduce risk for food allergy, according to a presentation at American Academy of Allergy, Asthma & Immunology Annual Meeting.

PHOENIX — A fecal microbiota transplant from healthy donors enabled patients with severe peanut allergy to safely eat small amounts of peanut, according to a presentation at American Academy of Allergy, Asthma & Immunology Annual Meeting.

One in three older adults reported one or more new or persistent COVID-19 symptoms following acute SARS-CoV-2 infection, researchers reported in BMJ.

PHOENIX — Racial disparities touch every aspect of clinical care for food allergies, from prevention and diagnosis to insurance coverage and to the diversity of the workforce providing treatment.

WAIKOLOA, Hawaii — In this Healio Video Perspective from Hawaiian Eye 2022, Michelle K. Rhee, MD, discusses the importance of contact lenses in serving younger patients.

A greater proportion of patients treated with Tremfya for moderate to severe ulcerative colitis achieved clinical remission at 12 weeks compared with placebo, according to Axel Dignass, MD, PhD, presenting author of a clinical study.

PHOENIX — Researchers for the first time sequenced the main allergen of macadamia nut and its cross-reactivity pattern with hazelnut, according to a poster presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

Poor maintenance of electronic health records may contribute to the low reported numbers of lifestyle interventions offered to individuals with high BP, high cholesterol or obesity in England, researchers reported.